Larimar Therapeutics, Inc. (LRMR)
Nasdaq: LRMR · CIK 0001374690 · United States
Every official Larimar Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open LRMR filings
Larimar Therapeutics, Inc. documents
- Larimar Therapeutics, Inc. 10-K 2026LRMR 10-K 2026: annual report for fiscal 2026
- Larimar Therapeutics, Inc. 10-K 2025LRMR 10-K 2025: annual report for fiscal 2025
- Larimar Therapeutics, Inc. 10-K 2024LRMR 10-K 2024: annual report for fiscal 2024
- Larimar Therapeutics, Inc. 10-K 2023LRMR 10-K 2023: annual report for fiscal 2023
- Larimar Therapeutics, Inc. 10-K 2022LRMR 10-K 2022: annual report for fiscal 2022
- Larimar Therapeutics, Inc. 10-Q 2026LRMR 10-Q 2026: quarterly report for fiscal 2026
- Larimar Therapeutics, Inc. 10-Q 2025LRMR 10-Q 2025: quarterly report for fiscal 2025
- Larimar Therapeutics, Inc. 10-Q 2024LRMR 10-Q 2024: quarterly report for fiscal 2024
- Larimar Therapeutics, Inc. 10-Q 2023LRMR 10-Q 2023: quarterly report for fiscal 2023
- Larimar Therapeutics, Inc. 10-Q 2022LRMR 10-Q 2022: quarterly report for fiscal 2022
- Larimar Therapeutics, Inc. 8-K 2026LRMR 8-K 2026: current report for fiscal 2026
- Larimar Therapeutics, Inc. 8-K 2025LRMR 8-K 2025: current report for fiscal 2025
- Larimar Therapeutics, Inc. 8-K 2024LRMR 8-K 2024: current report for fiscal 2024
- Larimar Therapeutics, Inc. 8-K 2023LRMR 8-K 2023: current report for fiscal 2023
- Larimar Therapeutics, Inc. 8-K 2022LRMR 8-K 2022: current report for fiscal 2022
- Larimar Therapeutics, Inc. DEF 14A 2026LRMR DEF 14A 2026: proxy statement for fiscal 2026
- Larimar Therapeutics, Inc. DEF 14A 2025LRMR DEF 14A 2025: proxy statement for fiscal 2025
- Larimar Therapeutics, Inc. DEF 14A 2024LRMR DEF 14A 2024: proxy statement for fiscal 2024
- Larimar Therapeutics, Inc. DEF 14A 2023LRMR DEF 14A 2023: proxy statement for fiscal 2023
- Larimar Therapeutics, Inc. DEF 14A 2022LRMR DEF 14A 2022: proxy statement for fiscal 2022
- Larimar Therapeutics, Inc. Form 4 2026LRMR Form 4 2026: insider trading filing for fiscal 2026
- Larimar Therapeutics, Inc. Form 4 2025LRMR Form 4 2025: insider trading filing for fiscal 2025
- Larimar Therapeutics, Inc. Form 4 2024LRMR Form 4 2024: insider trading filing for fiscal 2024
- Larimar Therapeutics, Inc. Form 4 2023LRMR Form 4 2023: insider trading filing for fiscal 2023
- Larimar Therapeutics, Inc. Form 4 2022LRMR Form 4 2022: insider trading filing for fiscal 2022
- Larimar Therapeutics, Inc. S-1 2026LRMR S-1 2026: registration statement for fiscal 2026
- Larimar Therapeutics, Inc. S-1 2025LRMR S-1 2025: registration statement for fiscal 2025
- Larimar Therapeutics, Inc. S-1 2024LRMR S-1 2024: registration statement for fiscal 2024
- Larimar Therapeutics, Inc. S-1 2023LRMR S-1 2023: registration statement for fiscal 2023
- Larimar Therapeutics, Inc. S-1 2022LRMR S-1 2022: registration statement for fiscal 2022
- Larimar Therapeutics, Inc. 13F 2026LRMR 13F 2026: institutional holdings for fiscal 2026
- Larimar Therapeutics, Inc. 13F 2025LRMR 13F 2025: institutional holdings for fiscal 2025
- Larimar Therapeutics, Inc. 13F 2024LRMR 13F 2024: institutional holdings for fiscal 2024
- Larimar Therapeutics, Inc. 13F 2023LRMR 13F 2023: institutional holdings for fiscal 2023
- Larimar Therapeutics, Inc. 13F 2022LRMR 13F 2022: institutional holdings for fiscal 2022
More companies